Tension and Trauma Releasing Exercises on Hypertensive Patients
Effect of Tension and Trauma Releasing Exercises on Quality of Life and Sleep in Patients With Hypertension
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to investigate the effect of Tension and Trauma Releasing Exercises (TRE) on the quality of life and sleep in hypertensive patients. Participants will perform a series of supervised TRE sessions, and their sleep quality, and quality of life will be assessed before and after the intervention to determine any potential improvements related to the exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedStudy Start
First participant enrolled
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2026
ExpectedNovember 21, 2025
November 1, 2025
4 months
November 17, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of life ,assessed by SF12
Change in SF-12 physical and mental component summary scores from baseline to 8 weeks.
Baseline and after 8 weeks of intervention
Sleep quality, assessed by the Pittsburgh Sleep Quality Index (PSQI).
Change in global PSQI score from baseline to 8 weeks. PSQI will be administered to assess sleep quality .
Baseline and 8 weeks after the start of the intervention
Secondary Outcomes (4)
Blood pressure - Systolic and Diastolic (mmHg) ,assessed by mercury sphygmomanometer
Baseline and 8 weeks after the start of the intervention
Heart rate ,assessed by pulse oximeter
Baseline and 8 weeks after the start of the intervention
Depression and anxiety ,assessed by Hospital Anxiety and Depression Scale (HADS)
Baseline and 8 weeks after the start of the intervention
Rate Pressure Product measurement
Baseline and 8 weeks after the start of the intervention
Study Arms (2)
"TRE Exercise Group"
EXPERIMENTALParticipants in this group will perform supervised Tension and Trauma Releasing Exercise (TRE) sessions in addition to their usual medical treatment for hypertension. The TRE sessions will be conducted three times per week for eight weeks, and each session will last approximately 30 minutes. The exercises aim to promote relaxation, reduce tension, and improve sleep quality, and quality of life.
"Control Group"
NO INTERVENTIONParticipants in this group will continue their usual medical treatment for hypertension without any additional exercise intervention. They will receive the same assessments for sleep quality, and quality of life as the experimental group.
Interventions
Tension and trauma releasing exercises will be conducted for study group only as follows: The exercises start by slightly fatiguing specific muscle groups to encourage this involuntary shaking, which is considered healthy and calming. The first exercise: Feet roll gently outward while shifting weight side to side, helping release ankle tension. The second exercise: One foot steps back while the front heel lifts until the calf feels lightly tired, triggering a small shake. The third exercise: A small lunge-like position engages the thighs and hips, leading to natural muscle release. The fourth exercise: A soft bend at the hips with relaxed arms and deep breathing stretches the back and encourages loosening. The fifth exercise: With feet wide and hands on the lower back, the hips push forward slightly while breathing deeply and turning gently side to side. The sixth exercise: The body slides into a seated position against a wall to lightly fatigue the
Eligibility Criteria
You may qualify if:
- Participants will be between 50 and 65 years of age.
- The BMI of patients will range between 30 and 34.9.
- Patients included in the study were diagnosed with essential hypertension for at least five years.
- The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg.
You may not qualify if:
- Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction.
- Patients are diagnosed with secondary hypertension.
- Patients with cognitive or physical impairments that prevent them from following instructions.
- e) Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate.
- f) Individuals with endocrine disorders or any condition known to influence hormonal levels.
- g) Patients are smokers. h) Malignant hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of physical therapy ,Cairo University
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
El-Sayed Essam Felaya, Assistant professor
Cairo University
- STUDY CHAIR
Salma Elsayed Elsheikh, Lecturer of physical therapy
Cairo University
- STUDY CHAIR
Mahmoud Mohamed Ghanema, Lecturer of Internal Medicine
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- BSc. in Physical Therapy, Cairo University, 2018
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 21, 2025
Study Start
November 18, 2025
Primary Completion
March 4, 2026
Study Completion (Estimated)
June 4, 2026
Last Updated
November 21, 2025
Record last verified: 2025-11